Jimenez-Colmenero F.,CSIC - Institute of Refrigeration
Food Research International | Year: 2013
Recent advances in food and nutrition sciences have highlighted the possibility of modulating some specific physiological functions in the organism through food intake. The beneficial effects of functional foods derive from dietary active compounds, and therefore the design and development of these foods require strategies to control their presence. Thanks to their characteristics, multiple emulsions can be used to induce qualitative and quantitative changes in food composition. This review provides an overview of the specific developments and food applications of multiple emulsions (W1/O/W2) as a technological strategy to modulate the presence of active dietary compounds for the development of healthier foods including functional foods. It discusses food-grade W1/O/W2 emulsion applications to: a) improve fat content, both by reducing fat (calories) content and providing healthier fatty acid profiles; b) encapsulate (protect) bioactive compounds such as minerals, carotenoids, vitamins, microorganisms, lactoferrin, phenolic compounds, amino acids and oils; and c) reduce sodium content. © 2013 Elsevier Ltd. Source
CSIC - Institute of Refrigeration | Date: 2014-05-29
The invention relates to transgenic plants and methods for modulating abscisic acid (ABA) perception and signal transduction in plants. The plants fmd use in increasing yield in plants, particularly under abiotic stress.
CSIC - Institute of Refrigeration | Date: 2014-02-12
The invention relates to the use of the insulin-like growth factor (IGF-1) as a reagent for the early diagnosis and/or prognosis of Alzheimer disease, to a kit comprising IGF-1 and a sedative, and to the use thereof in the early diagnosis and/or prognosis of Alzheimer disease.
CSIC - Institute of Refrigeration | Date: 2015-07-09
The invention relates to improving plant traits by expressing plant transcription factors in transgenic plants.
CSIC - Institute of Refrigeration and University of Gottingen | Date: 2014-05-07
Method and neuroprosthetic device for monitoring and suppression of pathological tremors in a user through the neurostimulation of the afferent pathways to the brain, which comprises wearable elements placed over the parts of the body affected by tremor, wherein said wearable elements (